ELV Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03
Prezzo $395.70
Capitalizzazione di Mercato (MRQ) $85.80B
P/E (TTM) 17.5
EPS (TTM) $22.59
Ricavi (TTM) $201.11B
Rendimento div. 1.8%
ROE (TTM) 11.2%
D/E Debito/Patrimonio (MRQ) 0.7
Intervallo 52 sett. $275–$436

ELV Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04
intervallo
barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Split azionari 1
Data ex-dividendo Split Tipo
01 Giugno 2005 2-for-1 Avanti

Informazioni su Elevance Health, Inc. Common Stock Panoramica della società da Wikipedia

05 · wikidata

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing (BPO)/Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States.

History

Anthem

In 1946, Anthem began in Indianapolis, Indiana, as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. The companies grew significantly, controlling 80% of the medical insurance market in Indiana by the 1970s.

In 1972, the two firms, then known as Blue Cross of Indiana and Blue Shield of Indiana, entered into a joint operating agreement.

In 1985, the two companies merged into Associated Insurance Companies, Inc,, later called, The Associated Group, a holding company, but usage of the name "Anthem" persisted. In 1989, the company purchased American General Insurance Co. for $150 million and in 1991, it acquired The Shelby Insurance Co., based in Shelby, Ohio, for $125 million. In 1989, The Associated Group founded Acordia, a brokerage that sold and serviced insurance and employee benefit programs.

In 1993, Acordia acquired American Business Insurance for $130 million and the Federal Kemper Insurance Company for $100 million. The Associated Group merged with Southeastern Mutual Insurance Company, the operator of Blue Cross and Blue Shield of Kentucky. In 1994, it sold Raffensperger, Hughes & Co., Inc., Indiana's largest investment bank, to National City Corp.

In 1995, The Associated Group acquired Community Mutual Insurance, a provider of Blue Cross and Blue Shield insurance plans in Ohio with over 1.9 million policy holders), then set up Anthem Blue Cross and Blue Shield. In 1996, The Associated Group changed its name to Anthem Insurance Company. In August 1997, Anthem acquired Blue Cross and Blue Shield of Connecticut. It also sold Acordia to management.

In 1999, Anthem acquired Blue Cross and Blue Shield of New Hampshire and Blue Cross and Blue Shield of Colorado and Nevada, using debt financing. The acquisitions made since 1996 added 850,000 policy holders. Among its customer base were 2.4 million PPO and 964,000 HMO enrollees.

In 2000, Anthem acquired Blue Cross Blue Shield of Maine. The Gramm-Leach-Bliley Act of 1999 made it possible for Anthem to undergo demutualization and become a public company via an initial public offering, which made it the fourth largest public managed health care company in the United States.

In 2002, Anthem acquired Trigon Healthcare of Virginia, a Blue Cross and Blue Shield plan, the largest insurer in Virginia, for $4.04 billion. Anthem Insurance Company reached 11.9 million members.

Blue Cross of California

Blue Cross of California was the predecessor of WellPoint Health Network Inc.

In 1982, Blue Cross of California was founded with the consolidation of Blue Cross of Northern California (established in 1936) and Blue Cross of Southern California (established in 1937).

In 1992, WellPoint was formed to operate Blue Cross of California's managed care business. In January 1993, Blue Cross of California spun off its managed care business into a publicly traded entity, WellPoint Health Networks Inc. Blue Cross of California retained an 80% interest and voting control.

In 1996, Blue Cross of California restructured to a for-profit corporation, designating WellPoint Health Networks Inc. as the parent organization. In April 1996, WellPoint completed its acquisition of Massachusetts Mutual Life Insurance Company's group life and health insurance subsidiaries for approximately $380 million, making it the second-largest publicly held managed health company in the U.S. with 4 million policyholders.

In March 1997, WellPoint acquired the group health and life businesses of John Hancock Financial for $86.7 million. With this acquisition, WellPoint expanded its presence into Michigan, Texas, and the mid-Atlantic, and gained a unit that concentrated on serving the needs of large employers.

In 2000, WellPoint acquired PrecisionRx, a mail service pharmacy fulfillment center in Texas. In March 2000, WellPoint acquired Rush Prudential Health Plans, a Chicago provider, for $204 million. In March 2001, WellPoint acquired Cerulean Companies, the parent company of Blue Cross Blue Shield of Georgia. In 2001, WellPoint offered to acquire CareFirst BlueCross BlueShield for $1.37 billion, including $119 million in bonuses to Carefirst executives. In 2003, the offer was rejected by the Maryland insurance commissioner.

In 2002, WellPoint acquired RightChoice Managed Care, a Missouri-based company that ran Blue Cross and Blue Shield for part of the state, for $1.5 billion. RightChoice also owned provider network company HealthLink. WellPoint also acquired MethodistCare of Houston, Texas and HealthLink. In 2003, WellPoint acquired Golden West Dental and Vision of Camarillo, California, and Cobalt, including Blue Cross and Blue Shield United of Wisconsin.

In November 2004, Wellpoint, Inc. was formed by the merger of Anthem Insurance Company and WellPoint Health Networks Inc. The merger was structured as Anthem acquiring WellPoint Health Networks and renaming itself WellPoint, Inc. WellPoint continued to use 'Anthem' as the brand name under which it operated. It sold its Blue Cross and Blue Shield products in 11 states.

In 2005, WellPoint acquired Alexandria, Virginia–based Lumenos, a provider of consumer-driven health care, for $185 million. Lumenos was the pioneer and market leader in consumer-driven health plans. In December, WellPoint acquired WellChoice, a New York City-based Blue Cross Blue Shield provider, for approximately $6.5 billion, making New York the 14th state in which WellPoint is a Blue Cross Blue Shield licensee.

In 2007, WellPoint acquired Chicago-based American Imaging Management, a radiology benefit management company that creates software to help physicians choose cost-effective locations for their patients to receive medical imaging tests. WellPoint also acquired Chicago-based American Imaging Management (AIM), the leading radiology benefit management company.

In January 2008, Leslie Margolin became the president of California operations. She resigned in July 2010. In 2008, WellPoint acquired Resolution Health, a firm that analyzes patient history for potential medical problems such as adverse drug interactions. In 2009, WellPoint acquired DeCare Dental, a dental insurance firm.

In 2011, WellPoint acquired CareMore, a Cerritos, California-based provider of insurance and care centers for elderly patients. In 2012, WellPoint acquired Amerigroup for $4.9 billion, anticipating significant growth due to Medicaid expansion under the Patient Protection and Affordable Care Act. In August 2012, CEO Angela Braly resigned due to pressure from investors.

On August 13, 2014, WellPoint announced it intended to change its name to Anthem, Inc., effective in December.

Anthem, Inc.

In February 2015, the company acquired Simply Healthcare Holdings, a Medicaid and Medicare managed care company based in Florida. In June 2015, Anthem made an offer to acquire Cigna for more than $54 billion in cash and stock. In February 2017, United States district court Judge Amy Berman Jackson blocked the Cigna merger on grounds of anti-competitive practices. On February 14, Cigna called off its merger agreement with Anthem.

In October 2017, Anthem announced that it would not renew its pharmacy benefit management (PBM) relationship with Express Scripts saying it had been overcharged $3 billion and that instead, Anthem would eventually handle the PBM process itself through its new IngenioRx unit. Anthem announced that it would enter a 5-year contract with CVS Health. Cigna then announced plans in March 2018 to acquire Express Scripts for $58 billion. On November 6, 2017, Gail Koziara Boudreaux was named CEO. In 2018, the company announced a $20 million expansion of its headquarters and the signing of a lease in Atlanta for its technology center. In March 2020, Anthem announced the acquisition of Beacon Health Options, and independently held behavioral health organization.

On February 2, 2021, Anthem announced the acquisition of InnovaCare Health's Puerto Rico subsidiaries including MMM Holdings, LLC ("MMM") and its Medicare Advantage (MA) plan MMM Healthcare, LLC as well as affiliated companies and Medicaid plan. In November 2021, Anthem announced the acquisition of Integra Managed Care in New York. The acquisition of the New York-based international health insurance company was completed on May 5, 2022.

On June 28, 2022, Anthem announced a change of its corporate name to Elevance Health, Inc. and also changed its stock ticker symbol from "ANTM" to "ELV".

Elevance Health

On January 23, 2023, Elevance announced that it entered a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana, increasing Elevance's footprint to 15 states and adding 1.9 million new members. In 2023, Elevance announced that it would rebrand its Amerigroup business as Wellpoint starting in 2024.

As of 2025, Elevance subsidiaries Carelon Behavioral Health and Anthem Blue Cross and Blue Shield are the subject of three lawsuits in New York and Connecticut alleging that they operate ghost networks.

Subsidiaries

Elevance Health includes the following subsidiaries:

Amerigroup

District of Columbia (Medicaid)

Georgia (Medicaid)

New Mexico (Medicare Advantage)

Anthem Blue Cross

California

Blue Cross of California Partnership Plan (Medicaid)

New York (upstate)

Anthem Blue Cross Blue Shield

Colorado

Connecticut

Georgia

Indiana (includes Medicaid)

Kentucky

Anthem Blue Cross and Blue Shield Medicaid

Maine

Missouri (excluding 30 counties in the Kansas City area)

Nevada

Anthem Blue Cross and Blue Shield Healthcare Solutions (Medicaid)

New Hampshire

New York (downstate)

HealthPlus (Medicaid)

Ohio

Virginia (excluding Alexandria City, Arlington County, Falls Church City, and parts of Fairfax County)

HealthKeepers (Medicaid)

Wisconsin

Carelon Behavioral Health

Carelon Behavioral Health of California

Carelon Behavioral Health of Kansas

Carelon Health of Pennsylvania

Carelon Global Solutions (Business Process Outsourcing/Shared Services)

Freedom Health

Florida

Golden West Dental & Vision

California

HealthSun

Florida

MMM

Puerto Rico

Optimum Healthcare

Florida

Simply Healthcare

Florida

UniCare

West Virginia

WellPoint

Arizona (Medicare Advantage)

Iowa (Medicaid and Medicare Advantage)

Maryland (Medicaid)

Massachusetts (government employees)

New Jersey (Medicaid and Medicare Advantage)

Tennessee (Medicaid and Medicare Advantage)

Texas (Medicaid and Medicare Advantage)

Washington (Medicaid and Medicare Advantage)

Joint ventures

Elevance Health operates joint ventures including:

Anthem | MaineHealth (with MaineHealth)

Maine

Blue Medicare Advantage (with Independence Blue Cross)

Pennsylvania

Colorado Community Health Alliance (with Centura Health, Physician Health Partners and Primary Physician Partners)

Colorado

Healthy Blue Kansas (with Blue Cross and Blue Shield of Kansas and Blue Cross and Blue Shield of Kansas City)

Kansas

Healthy Blue Louisiana (with Blue Cross Blue Shield of Louisiana)

Louisiana

Summit Community Care

Arkansas

Centers Plan for Healthy Living

New York, Florida

Quality of care

In 2011, in the category of "Meeting National Standards of Care," California's state patient advocacy office gave Anthem a rating of 2 out of 4 stars. In 2014, it received 3 out of 4 stars in the same category. In 2022, twenty-one of Elevance Health's affiliated Medicaid plans earned accreditation for health equity from the National Committee for Quality Assurance (NCQA).

Controversies

Charitable donations

In 2007, WellPoint pledged to spend $30 million over three years, through the company's charitable foundation, to help the uninsured. In March 2010, the Los Angeles Times reported that WellPoint's tax records and website showed that the company had given only $6.2 million by 2009. The company said that the foundation had indeed fulfilled its $30-million commitment by mid-2009, but refused to provide any financial details to support its claim.

2007 DMHC investigation

In 2007, the California Department of Managed Health Care (DMHC) investigated Anthem's policies for revoking (rescinding) health care insurance policies. The DMHC randomly selected 90 instances where Anthem canceled the insurance of policy holders who had been diagnosed with costly or life-threatening illnesses, to find how many of these cancellations were legal. The agency concluded that all these cancellations were illegal.

In July 2008, Anthem Blue Cross agreed to a settlement with the California Department of Managed Health Care; however in doing so, WellPoint did not officially admit liability. To resolve allegations of improper policy rescissions (cancellations), WellPoint paid $10 million and reinstated plans for 1,770 policy-holders who were affected by cancelled policies. The company also agreed to provide compensation for any medical debts incurred by these policy-holders.

2010 Reuters exposé

In April 2010, Reuters alleged that Wellpoint "using a computer algorithm, identified women recently diagnosed with breast cancer and then singled them out for cancellation of their policies." The software used immediately triggered fraud investigation for those recently diagnosed with the disease as the company searched for some pretext to drop their policies. Wellpoint argued that its algorithm was scanning for diagnostic codes for conditions that patients might have known about during the insurance application. The story not only caused considerable public outrage, but it also led Secretary of Health and Human Services, Kathleen Sebelius, and President Barack Obama, to call on WellPoint to end the practice.

In 2011, Anthem began cancelling policies of members who had been paying premiums with credit cards, sometimes without calling or emailing the member ahead of time.

Opposition to healthcare reform

In August 2009, Anthem, the largest for-profit insurer in California, contacted its employees and urged them to get involved to oppose healthcare reforms proposed during the Obama administration. Consumer Watchdog, a nonprofit watchdog organization in Santa Monica, asked California Attorney General Jerry Brown to investigate its claim that WellPoint had illegally pushed workers to write to their elected officials, attend town hall meetings and enlist family and friends to ensure an overhaul that would match the firm's interests. According to Consumer Watchdog, California's labor code directly prohibits coercive communications, including forbidding employers from controlling, coercing or influencing employees' political activities or affiliations. WellPoint had not been contacted by the California attorney general and had not seen any complaint.

Through 2010 and into 2011, WellPoint senior executives met monthly with executives of other major health insurers to blunt the effect of the Patient Protection and Affordable Care Act.

Premium increases in Maine

In 2009, Anthem Health Plans of Maine, a WellPoint subsidiary, sued the state of Maine for the right to increase premiums further. Since Maine licenses insurance companies through its Bureau of Insurance, Anthem needed the state's permission to raise rates. The Court disagreed with Anthem and found that, unlike with other forms of insurance, the Maine Insurance Code does not require the Superintendent to consider profits.

Rate increases in California

In February 2010, WellPoint announced that rates would increase on some Anthem Blue Cross individual policies in California by as high as 39%. The announcement resulted in an investigation by regulators from the Federal and California governments. Anthem Blue Cross gained worldwide media attention and became a poster child for the problem of rising cost of health care in the U.S. The rate increase came one year after Anthem had raised rates 68% on individual policy holders.

To explain the rate increases, some which were four times the rate of medical inflation, Anthem said the company had experienced a death spiral: the company claimed that with increased unemployment and declining wages, healthy customers dropped their insurance policies. Consequently, the remaining risk pool became sicker and thus more expensive to insure; and, in turn, prices were forced up and pushed more people out of the market.

In response to the outrage from politicians and consumers, Anthem postponed the rate increase until May 1, 2010.

Senator Dianne Feinstein of California proposed giving the Federal government of the United States authority to block insurance premium hikes that it considers to be "unjustified".

WellPoint cost reclassification

On March 17, 2010, WellPoint announced it was reclassifying some of its administrative costs as medical care costs in order to meet loss ratio requirements under the Patient Protection and Affordable Care Act, which requires insurers to spend at least 80% or 85% of customer premiums on health care services, depending on the type of plan.

2009–2010 data breach

In June 2010, Anthem sent letters to 230,000 customers in California warning them that their personal data might have been accessed online via a data breach. After a routine upgrade in October 2009, a third-party vendor stated that all security measures had been properly reinstated, when in fact they had not. As a result, personal information of thousands of coverage applicants who were under the age of 65 was exposed in the open. After a Los Angeles-area woman found that her application for coverage was publicly available, she filed a class action lawsuit against Anthem. While gathering evidence for the proceeding, the woman's lawyers downloaded some confidential customer information from Anthem's website and alerted Anthem about the breach. According to the lawyers, confidential information had remained exposed for five months. Greg Zoeller, Indiana's Attorney General, filed a lawsuit against the company seeking $300,000 in civil penalties for the company alleged failure to notify its consumers about the breach.

Denial of benefits for cancer treatment

In May 2014, Anthem Blue Cross refused to pay for the hospitalization of a Sonoma County, California man for stage four cancers, although he had paid Anthem over $100,000 in premiums. Anthem ended up paying for coverage following public outcry.

2015 data breach

On February 4, 2015, Anthem, Inc. disclosed that criminal hackers had broken into its servers and potentially stolen over 37.5 million records that contain personally identifiable information from its servers. According to Anthem, Inc., the data breach extended into multiple brands Anthem, Inc. uses to market its healthcare plans, including, Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross and Blue Shield, Amerigroup, Caremore, and UniCare. Healthlink was also victimized. Anthem says the medical information and financial data was not compromised. Anthem has offered free credit monitoring in the wake of the breach. According to Bloomberg News, China may be responsible for this data breach. Michael Daniel, chief adviser on cybersecurity for President Barack Obama, said he would be changing his own password. About 80 million company records were hacked, stoking fears that the stolen data could be used for identity theft. The compromised information contained names, birthdays, medical IDs, social security numbers, street addresses, e-mail addresses, employment information and income data. In June 2017, Anthem agreed to spend $115M to settle allegations that it failed to adequately protect the data of its clients, the sum was to be spent on two years of services to protect victims from identity theft. In 2019, two Chinese nationals were indicted for the breach.

"Avoidable ER program"

Beginning in 2015, Anthem has been implementing and expanding its "avoidable ER program" which means not reimbursing ER visits when the cause is not covered by the company. A few patients found out that they had been stuck with bills of over $10,000 that Anthem refused to reimburse. According to a 2013 report by the Journal of the American Medical Association, 87 percent of patients initially triaged as non-urgent ended up with a diagnosis that constituted an emergency. Critics derided the scheme, citing that it was unlawful by federal law to cover a person based on diagnosis, not symptoms. It was also considered unsafe, as it pressured patients to diagnose themselves before going to the ER.

Neglecting complaints

In 2017, the California Department of Managed Health Care fined the company $5 million for untimely response to consumer complaints. In 2019, this was settled at $2.8 million.

2019 lawsuit for coercive direct payments

In 2019, Sovereign Health pressed charges against Anthem, alleging that it was using direct payments to compel them to join Anthem's network under unfavorable terms. Sovereign owns facilities that treat people with addiction and mental health problems.

Diagnostics fraud

In March 2020, Anthem was sued by the Department of Justice. The lawsuit alleges that Anthem had submitted inaccurate diagnostics data in order to obtain increased Medicare reimbursements. In October 2022, a judge ordered Anthem to face the lawsuit.

Medicare Advantage star rating

In January 2024, Elevance Health filed a lawsuit with the Department of Health and Human Services (HHS) challenging changes in the Medicare Advantage star rating methodology. Star ratings are tied to key bonus payouts, and due to the new rating system in 2024 ratings have significantly decreased.

Finances

For the fiscal year 2017, Anthem reported earnings of US$3.843 billion, with an annual revenue of US$90.039 billion, an increase of 6.1% over the previous fiscal cycle. Anthem's shares traded at over $183 per share, and its market capitalization was valued at over US$69.1 billion in October 2018.

Recognition

The company was featured on the S&P Dow Jones Sustainability Index from 2018 to 2022, was named by Fortune as one of the 100 Best Companies to Work For, and was included on the Corporate Equality Index's list of Best Places to Work for LGBTQ Equality from 2015 to 2022.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

settoreHealth Care industriaHealth Care dipendenti96.129 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06
Ricavi$199.12B
2016-12-31 → 2025-12-31
EPS$25.21
2016-12-31 → 2025-12-31
Flusso di cassa libero$3.17B
2016-12-31 → 2025-12-31
Margine netto2.5%
2016-12-31 → 2025-12-31
Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica Tendenza 5 anni ELV media 5 anni Mediana dei peer Verdetto
P/E (TTM) 17.5media 5 anni ≈17.3 ≈17.3 36.3 Sottovalutato
P/S (TTM) 0.4media 5 anni ≈0.6 ≈0.6 0.7 Sottovalutato
P/B (MRQ) 1.9media 5 anni ≈2.6 ≈2.6 3.9 Sottovalutato
EV / EBITDA 12.6media 5 anni ≈12.8 ≈12.8 16.1 Sottovalutato
Prezzo / FCF (TTM) 13.6media 5 anni ≈18.3 ≈18.3 · ·
Prezzo / Flusso di cassa (TTM) 11.5media 5 anni ≈14.8 ≈14.8 15.6 Sopravvalutato
EV / Revenue (EV / Ricavi) 0.6media 5 anni ≈0.7 ≈0.7 · ·
EV / FCF 34.6media 5 anni ≈22.2 ≈22.2 · ·
Prezzo / Valore contabile tangibile (MRQ) 2.5media 5 anni ≈61.0 ≈61.0 · ·
PEG Ratio ≈2.5 · · ·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

13
Dividend Yield1.8%
Rapporto di Distribuzione Utili27.0%
Pagamento annualizzato≈$6.88Pagato trimestralmente
CAGR Dividendi 5Y≈12.5%Per azione, rettificato per lo split
Striscia di crescita≈13Anni consecutivi di crescita dei dividendi
Data ex-dividendoImportoValutaRendimento
Set 10, 2026$1,72USD≈1.6%
Giu 10, 2026$1,72USD≈1.7%
Mar 10, 2026$1,72USD≈2.4%
Dic 5, 2025$1,71USD≈2.1%
Set 10, 2025$1,71USD≈2.2%
Giu 10, 2025$1,71USD≈1.7%
Mar 10, 2025$1,71USD≈1.6%
Dic 5, 2024$1,63USD≈1.7%
Set 10, 2024$1,63USD≈1.2%
Giu 10, 2024$1,63USD≈1.2%
Mar 7, 2024$1,63USD≈1.2%
Dic 5, 2023$1,48USD≈1.2%
Set 7, 2023$1,48USD≈1.3%
Giu 8, 2023$1,48USD≈1.2%
Mar 9, 2023$1,48USD≈1.2%
Dic 2, 2022$1,28USD≈0.98%
Set 8, 2022$1,28USD≈1.0%
Giu 9, 2022$1,28USD≈0.99%
Mar 9, 2022$1,28USD≈1.0%
Dic 2, 2021$1,13USD≈1.1%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14
Sorpresa media 10.5%
Prossimo report Ott 19, 2026
PeriodoRapportoEPS ActualEPS StimatoSorpresa
30 Giugno 2026 Lug 15, 2026 $7.45 $6.27 18.9%
31 Marzo 2026 $12.58 $10.93 15.1%
31 Dicembre 2025 $3.33 $3.13 6.5%
30 Settembre 2025 $6.03 $4.98 21.0%
30 Giugno 2025 $8.84 $9.04 -2.3%
31 Marzo 2025 $11.97 $11.50 4.1%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15
Conto Economico 13
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue $199.12B$177.01B$171.34B$156.59B$138.64B$121.87B$104.21B$92.11B$90.04B$84.86B$79.16B$73.87B
Cost of Revenue $21.18B$19.75B$17.29B$13.04B$10.89B$8.95B$1.99B$0$0···
SG&A Expense $20.98B$20.02B$20.09B$17.70B$15.92B$17.45B$13.36B$14.02B$12.65B$12.56B$12.53B$11.75B
Operating Income $7.20B$7.86B$8.50B$8.28B$7.56B$6.36B$6.00B$5.43B$4.17B$4.80B$4.75B$4.42B
Interest Expense ··$1.03B$851M$798M$784M$746M$753M$739M$723M$653M$601M
Pretax Income $6.71B$7.90B$7.71B$7.60B$8.00B$6.24B$5.99B$5.07B$3.96B$4.55B$4.63B$4.37B
Income Tax $1.05B$1.93B$1.72B$1.71B$1.85B$1.67B$1.18B$1.32B$121M$2.08B$2.07B$1.81B
Net Income $5.66B$5.98B$5.99B$5.89B$6.16B$4.57B$4.81B$3.75B$3.84B$2.47B$2.56B$2.57B
EPS (Basic) $25.28$25.81$25.38$24.56$25.26$18.23$18.81$14.53$14.70$9.39$9.73$9.31
EPS (Diluted) $25.21$25.68$25.22$24.28$24.95$17.98$18.47$14.19$14.35$9.21$9.38$8.99
Shares (Basic) 224,000,000231,700,000235,900,000240,000,000243,800,000250,800,000255,500,000258,100,000261,500,000262,900,000263,000,000275,900,000
Shares (Diluted) 224,600,000232,900,000237,400,000242,800,000246,800,000254,300,000260,300,000264,200,000267,800,000268,100,000272,900,000285,900,000
EBITDA $8.74B$9.26B$10.24B$10.13B$8.79B$7.51B$6.00B$5.43B$4.18B$4.80B$4.75B$4.42B
Stato Patrimoniale 26
Metrica Tendenza 202520242023202220212020201920182017201620152014
Cash & Equivalents $9.49B$8.29B$6.53B$7.39B$4.88B$5.74B$4.94B$3.93B$3.61B$4.08B$2.11B$2.15B
Other Current Assets $5.34B$4.70B$5.79B$5.28B$4.65B$4.06B$3.02B$2.10B$2.25B$1.78B$1.56B$1.47B
Current Assets $63.00B$58.94B$60.03B$55.62B$51.12B$45.75B$39.03B$34.32B$36.26B$34.31B$30.86B$31.95B
PP&E (Net) $4.68B$4.65B$4.36B$4.32B$3.92B$3.48B$3.13B$2.73B$2.17B$1.98B$2.02B$1.94B
PP&E (Gross) $8.73B$8.33B$7.90B$7.12B$8.26B$7.33B$6.48B$5.55B$4.37B$4.14B$4.06B$3.76B
Accum. Depreciation $4.06B$3.68B$3.54B$2.80B$4.34B$3.84B$3.35B$2.81B$2.20B$2.16B$2.04B$1.82B
Goodwill $28.34B$28.28B$25.32B$24.38B$24.23B$21.69B$20.50B$20.50B$19.23B$17.56B$17.56B$17.08B
Intangibles $11.20B$12.09B$10.27B$10.31B$10.62B$9.40B$8.67B$9.01B$8.37B$7.96B$8.16B$7.96B
Other Non-current Assets $2.31B$2.14B$1.97B$1.69B$1.72B$1.44B$1.35B$758M$565M$468M$485M$512M
Total Assets $121.49B$116.89B$108.93B$102.75B$97.46B$86.61B$77.45B$71.57B$70.54B$65.08B$61.72B$61.68B
Accounts Payable $7.32B$6.93B$6.91B$5.61B$4.97B$5.49B$4.20B$4.96B$5.02B$4.01B$3.32B$3.65B
Short-term Debt $150M$365M$225M$265M$275M$0$700M$1.15B$1.27B$440M$540M$400M
Current Liabilities $41.03B$40.58B$41.79B$39.70B$34.88B$29.45B$23.53B$21.96B$23.36B$21.29B$19.09B$18.75B
Capital Leases $529M$658M$685M$751M$864M·······
Deferred Tax $2.11B$2.15B$1.97B$2.02B$2.81B$2.02B$2.23B$1.96B$1.73B$2.78B$2.63B$2.95B
Other Non-current Liabilities $3.53B$3.33B$1.74B$1.56B$1.68B$1.81B$1.42B$1.18B$925M$884M$994M$1.04B
Total Liabilities $77.47B$75.46B$69.52B$66.42B$61.29B$53.42B$45.73B$43.03B$44.04B$39.98B$38.67B$37.42B
Long-term Debt $31.90B$30.87B$24.89B$23.85B$22.76B$20.04B$19.39B$18.07B$18.66B$15.29B$15.32B$14.64B
Total Debt $32.05B$31.23B$25.12B$24.11B$23.03B$20.04B$20.09B$19.21B$19.93B$15.73B$15.86B$15.15B
Common Stock $2M$2M$2M$2M$2M$3M$3M$3M$3M$3M$3M$3M
Paid-in Capital $8.94B$8.91B$8.87B$9.08B$9.15B$9.24B$9.45B$9.54B$8.55B$8.81B$8.56B$10.06B
Retained Earnings $35.39B$33.55B$31.75B$29.65B$27.14B$23.80B$22.57B$19.99B$18.05B$16.56B$14.78B$14.01B
AOCI $-451M$-1.15B$-1.31B$-2.49B$-197M$150M$-296M$-986M$-101M$-268M$-293M$172M
Stockholders' Equity $43.88B$41.31B$39.31B$36.24B$36.09B$33.20B$31.73B$28.54B$26.50B$25.10B$23.05B$24.25B
Liabilities + Equity $121.49B$116.89B$108.93B$102.75B$97.46B$86.61B$77.45B$71.57B$70.54B$65.08B$61.72B$61.68B
Shares Outstanding 220,723,898227,479,695233,071,088237,958,067241,770,746245,401,430252,922,161257,395,577256,084,913263,747,395261,238,188268,109,932
Flusso di cassa 18
Metrica Tendenza 202520242023202220212020201920182017201620152014
D&A $1.55B$1.39B$1.75B$1.68B$1.30B$1.15B$1.13B$1.13B····
Stock-based Comp $276M$191M$289M$264M$255M$283M$294M$226M$170M$165M$148M$169M
Deferred Tax $-279M$-374M$-602M$-115M$342M$-540M$81M$91M$-1.27B$127M$-66M$31M
Amort. of Intangibles $628M$580M$885M$767M$441M$361M$338M$358M$169M$192M$230M$221M
Other Non-cash $-2.92B$-1.38B$642M$511M$377M$5.22B······
Operating Cash Flow $4.29B$5.81B$8.06B$8.40B$8.36B$10.69B$6.06B$3.83B$4.18B$3.27B$4.21B$3.37B
CapEx $1.12B$1.26B$1.30B$1.15B$1.09B$1.02B$1.08B$1.21B$791M$584M$638M$715M
Investing Cash Flow $-1.34B$-5.17B$-5.57B$-4.56B$-9.64B$-7.32B$-2.79B$-1.26B$-5.08B$-514M$-1.15B$-975M
Debt Issued $2.99B$7.71B$2.57B$3.07B$3.46B$2.48B$2.47B$835M$5.46B$0$1.23B$2.70B
Net Debt Issued $844M$6.06B$665M$1.17B$2.39B$552M$1.35B$-849M$2.64B$0$-1.47B$970M
Stock Issued ·····$0$0$1.25B$0$0··
Stock Repurchased $2.60B$2.90B$2.68B$2.32B$1.90B$2.70B$1.70B$1.69B$2.00B$0$1.52B$3.00B
Net Stock Activity $-2.60B$-2.90B$-2.68B$-2.32B$-1.90B$-2.70B$-1.70B$-435M$-2.00B$0$-1.52B$-3.00B
Dividends Paid $1.53B$1.51B$1.40B$1.23B$1.10B$954M$818M$776M$705M$684M$657M$481M
Financing Cash Flow $-1.74B$1.19B$-3.35B$-1.32B$423M$-2.57B$-2.27B$-2.24B$427M$-799M$-3.09B$-1.82B
Net Change in Cash $1.20B$1.83B$-861M$2.51B$-861M$804M$1.00B$325M$-466M$1.96B$-38M$565M
Free Cash Flow $3.17B$4.55B$6.76B$7.25B$7.28B$9.67B$4.98B$2.62B$3.39B$2.62B$3.48B$2.65B
Levered FCF ··$5.97B$6.59B$6.66B$9.09B$4.38B$2.06B$2.67B$2.23B$3.12B$2.30B
Redditività 7
Metrica Tendenza 202520242023202220212020201920182017201620152014
Operating Margin 3.6%4.4%5.0%5.4%5.4%5.2%5.8%5.9%4.6%5.7%6.0%6.0%
Net Margin 2.8%3.4%3.5%3.9%4.4%3.8%4.6%4.1%4.3%2.9%3.2%3.5%
Pretax Margin 3.4%4.5%4.5%5.0%5.7%5.1%5.7%5.5%4.4%5.4%5.9%5.9%
EBITDA Margin 4.4%5.2%6.0%6.5%6.3%6.2%5.8%5.9%4.6%5.7%6.0%6.0%
ROA 4.8%5.3%5.7%6.0%6.6%5.6%6.5%5.3%5.7%3.9%4.2%4.2%
ROE 13.3%14.8%15.8%16.7%17.0%13.6%15.2%13.0%14.6%9.9%11.1%10.6%
ROIC 8.0%8.2%10.2%10.8%9.8%8.8%9.3%8.4%8.7%6.4%6.8%6.6%
Liquidità e Solvibilità 5
Metrica Tendenza 202520242023202220212020201920182017201620152014
Current Ratio 1.51.51.41.41.51.61.71.61.61.61.61.7
Quick Ratio 0.20.20.20.20.10.20.20.20.20.20.10.1
Debt / Equity 0.70.80.60.70.60.60.60.70.80.60.70.6
LT Debt / Equity 0.70.70.60.60.60.60.60.60.70.60.70.6
Interest Coverage ··8.39.99.48.18.07.25.76.67.37.4
Efficienza 1
Metrica Tendenza 202520242023202220212020201920182017201620152014
Asset Turnover 1.71.61.61.61.51.51.41.31.31.31.31.2
Per Azione 6
Metrica Tendenza 202520242023202220212020201920182017201620152014
Book Value / Share $198.81$181.62$168.64$152.58$149.15$135.28$125.45$110.88$103.49$95.17$88.21$90.45
Revenue / Share $886.58$760.03$721.74$644.95$561.75$479.23$400.36$348.62$336.22$316.53$290.06$258.39
Cash Flow / Share $19.10$24.94$33.96$34.59$33.89$42.03$23.28$14.49$15.63$11.95$15.08$11.78
Cash / Share $43.00$36.43$28.00$31.04$20.18$23.39$19.52$15.28$14.09$15.45$8.09$8.03
Dividend / Share ··$5.92$5.12$4.52$3.80$3.20$3.00$2.70$2.60$2.50$1.75
EPS (TTM) $25.21$25.68$25.22$24.28$24.95$17.98$18.47$14.19$14.35$9.21$9.38$8.99
Tassi di Crescita 10
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue YoY 12.5%3.3%9.4%13.0%13.8%·······
Revenue CAGR 3Y 8.3%8.5%12.0%·········
Revenue CAGR 5Y 10.3%···········
EPS YoY -1.8%1.8%3.9%-2.7%38.8%·······
EPS CAGR 3Y 1.3%0.97%11.9%·········
EPS CAGR 5Y 7.0%···········
Net Income YoY -5.3%-0.12%1.6%-4.3%34.7%·······
Net Income CAGR 3Y -1.3%-0.97%9.4%·········
Net Income CAGR 5Y 4.4%···········
Dividends Paid CAGR 5Y 9.9%···········
Valutazione (TTM) 17
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue TTM $199.12B$177.01B$171.34B$156.59B$138.64B$121.87B$104.21B$92.11B$90.04B$84.86B$79.16B$73.87B
Net Income TTM $5.66B$5.98B$5.99B$5.89B$6.16B$4.57B$4.81B$3.75B$3.84B$2.47B$2.56B$2.57B
Market Cap $77.37B$83.92B$109.91B$122.07B$112.07B$78.80B$76.39B$67.60B$57.62B$37.92B$36.43B$33.69B
Enterprise Value $99.93B$106.86B$128.50B$138.79B$130.22B$93.09B$91.54B$82.88B$73.94B$49.57B$50.18B$46.69B
P/E 13.914.418.721.118.617.916.418.515.715.614.914.0
P/S 0.40.50.60.80.80.60.70.70.60.40.50.5
P/B 1.82.02.83.43.12.42.42.42.21.51.61.4
P / Tangible Book 17.888.929.679.089.537.5······
P / Cash Flow 18.014.413.614.513.47.412.617.713.811.88.910.0
P / FCF 24.418.416.216.815.48.215.325.817.014.510.512.7
EV / EBITDA 11.411.512.513.714.812.415.315.317.710.310.610.6
EV / FCF 31.523.519.019.217.99.618.431.621.818.914.417.6
EV / Revenue 0.50.60.80.90.90.80.90.90.80.60.60.6
Dividend Yield 2.0%1.8%1.3%1.0%0.99%1.2%1.1%1.1%1.2%1.8%1.8%1.4%
Earnings Yield 7.2%7.0%5.3%4.7%5.4%5.6%6.1%5.4%6.4%6.4%6.7%7.1%
Payout Ratio 27.0%25.2%23.3%20.4%18.1%20.9%17.0%20.7%18.3%27.7%25.7%18.7%
Annual Payout $1.53B$1.51B$1.40B$1.23B$1.10B$954M$818M$776M$705M$684M$657M$481M

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16
Metrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Ricavi $199.12B $177.01B $171.34B $156.59B $138.64B
Margine Operativo % 3.6% 4.4% 5.0% 5.4% 5.4%
Utile netto $5.66B $5.98B $5.99B $5.89B $6.16B
EPS Diluito $25.21 $25.68 $25.22 $24.28 $24.95

Proprietari istituzionali (13F) 1.757 filer · $81.9B totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 1.757
Valore detenuto $81.9B
Nuove posizioni 264
Posizioni chiuse 94
Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
264 (+89 vs trimestre precedente) 94 (-110 vs trimestre precedente) 609 (+128 vs trimestre precedente) 550 (-104 vs trimestre precedente) +6.8M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
VANGUARD GROUP INC $8.069.492.034 23.019.518 9,86% Azioni
BlackRock, Inc. $7.344.424.106 18.991.090 8,97% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $5.436.729.233 14.058.204 6,64% Azioni
STATE STREET CORP $4.032.282.885 10.426.610 4,93% Azioni
WELLINGTON MANAGEMENT GROUP LLP $3.563.141.883 9.213.513 4,35% Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC $2.403.277.896 6.214.356 2,94% Azioni
Sanders Capital, LLC $2.252.711.532 5.825.024 2,75% Azioni
GEODE CAPITAL MANAGEMENT, LLC $1.990.239.599 5.166.124 2,43% Azioni
HARRIS ASSOCIATES L P $1.904.455.957 4.924.511 2,33% Azioni
Artisan Partners Limited Partnership $1.771.695.984 4.581.222 2,16% Azioni
Invesco Ltd. $1.637.504.097 4.234.231 2,00% Azioni
First Eagle Investment Management, LLC $1.619.701.186 4.188.196 1,98% Azioni
NORGES BANK $1.531.008.381 3.958.856 1,87% Azioni
Bank of New York Mellon Corp $1.246.348.719 3.222.787 1,52% Azioni
FMR LLC $1.211.103.818 3.131.652 1,48% Azioni
MORGAN STANLEY $1.007.728.234 2.605.764 1,23% Azioni
NORTHERN TRUST CORP $817.928.536 2.114.986 1,00% Azioni
CITIGROUP INC $810.919.703 2.096.863 0,99% Azioni
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $779.725.026 2.016.200 0,95% Azioni
GOLDMAN SACHS GROUP INC $775.630.749 2.005.613 0,95% Azioni
Nuveen, LLC $769.539.548 1.989.863 0,94% Azioni
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $749.415.810 1.935.880 0,92% Azioni
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $737.324.542 2.518.615 0,90% Azioni
BANK OF AMERICA CORP /DE/ $698.537.689 1.806.267 0,85% Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $697.546.062 1.803.703 0,85% Azioni
Legal & General Group Plc $688.469.125 1.780.232 0,84% Azioni
Grantham, Mayo, Van Otterloo & Co. LLC $654.221.093 1.691.671 0,80% Azioni
Amundi $635.991.799 1.644.537 0,78% Azioni
DIMENSIONAL FUND ADVISORS LP $601.132.524 1.554.359 0,73% Azioni
MANUFACTURERS LIFE INSURANCE COMPANY, THE $591.084.393 1.528.416 0,72% Azioni
EAGLE CAPITAL MANAGEMENT LLC $576.772.638 1.491.409 0,70% Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $511.706.827 1.323.163 0,63% Azioni
VANGUARD FIDUCIARY TRUST CO $461.498.831 1.193.336 0,56% Azioni
BAILLIE GIFFORD & CO $418.920.245 1.083.237 0,51% Azioni
JPMORGAN CHASE & CO $386.949.330 997.214 0,47% Azioni
Ruane, Cunniff & Goldfarb L.P. $378.839.935 979.598 0,46% Azioni
Brave Warrior Advisors, LLC $377.790.736 976.885 0,46% Azioni
Newport Trust Company, LLC $369.294.278 954.915 0,45% Azioni
DEUTSCHE BANK AG\ $364.707.273 943.054 0,45% Azioni
FRANKLIN RESOURCES INC $360.834.432 933.040 0,44% Azioni
1832 Asset Management L.P. $355.109.795 918.237 0,43% Azioni
CITADEL ADVISORS LLC $350.526.658 906.386 0,43% Azioni
Capital International Investors $290.732.899 751.772 0,36% Azioni
UBS Group AG $286.115.618 739.833 0,35% Azioni
ACR Alpine Capital Research, LLC $285.376.389 737.922 0,35% Azioni
MILLENNIUM MANAGEMENT LLC $281.369.666 727.561 0,34% Azioni
ROYAL BANK OF CANADA $268.753.000 694.935 0,33% Azioni
High Ground Investment Management LLP $262.939.273 679.904 0,32% Azioni
CANADA PENSION PLAN INVESTMENT BOARD $261.530.030 676.260 0,32% Azioni
Qube Research & Technologies Ltd $247.577.198 640.181 0,30% Azioni

Mostra tutti i 1.757 proprietari istituzionali →

Insider aziendali 95 insider · 57 dirigenti · 37 direttori

19
Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
Gail Boudreaux President and CEO 17 Luglio 2026 P 171.976 2 0 $1.002.230
Brian T Griffin EVP & CEO, IngenioRx 03 Maggio 2018 M 15.863 0 0 $0
Angela F Braly Chair, President & CEO 01 Marzo 2012 A 476.503 0 0 $0
Brian A Sassi President & CEO Cons, EVP 07 Giugno 2011 S 60.825 0 0 $0
Dijuana K Lewis Pres & CEO CHS and EVP 20 Maggio 2010 M 44.107 0 0 $0
Mark L Boxer Pres & CEO of OT&GS and EVP 04 Aprile 2008 F 42.143 0 0 $0
Joan E Herman President & CEO Cons and EVP 07 Dicembre 2007 S 30.369 0 0 $0
Mark Kaye EVP & CFO 02 Marzo 2026 A 32.037 0 0 $0
John E Gallina EVP & Chief Financial Officer 01 Marzo 2023 A 63.725 0 0 $0
Wayne S Deveydt EVP & Chief Financial Officer 03 Marzo 2016 F 57.957 0 0 $0
David C Colby Vice Chairman, CFO & EVP 04 Aprile 2007 F 343.071 0 0 $0
Thomas R Byrd President, Anthem Specialty 26 Novembre 2004 A 26.580 0 0 $0
Michael D Houk President, National Accounts 04 Novembre 2004 M 18.843 0 0 $0
John M Murphy President, Specialty Business 17 Maggio 2004 A 20.806 0 0 $0
Caroline S Matthews Chief Operating Officer 01 Dicembre 2004 A 40.471 0 0 $0
Erin M Wessling EVP & Chief Legal Officer 03 Settembre 2026 F 7.230 0 0 $0
Ryan R Craig EVP & Chief HR Officer 02 Settembre 2026 F 6.530 0 0 $0
Ronald W Penczek CAO & Controller 12 Giugno 2026 S 3.740 0 2 $-765.958
Charles Morgan Kendrick JR EVP & President, Commercial 06 Marzo 2026 S 11.791 0 1 $-910.604
Peter D Haytaian EVP & Pres Carelon & CarelonRx 03 Marzo 2026 F 27.222 0 0 $0
Felicia F Norwood EVP &Chief Health Benefits Ofr 02 Marzo 2026 A 38.838 0 0 $0
Ratnakar Lavu EVP & Chief Digital Info Ofr 02 Marzo 2026 A 16.149 0 0 $0
Blair Williams Todt EVP, CLO & CAO 03 Gennaio 2025 F 15.631 0 0 $0
Gloria M Mccarthy EVP & Chief Administrative Off 24 Marzo 2023 S 51.435 0 0 $0
Leah Stark EVP & CHRO 30 Dicembre 2021 F 12.403 0 0 $0
Jeffrey D. Alter EVP, IngenioRx & Anthem Health 01 Ottobre 2021 F 5.107 0 0 $0
Patel Prakash R EVP & President, DBG 04 Settembre 2021 F 17.230 0 0 $0
Thomas C Zielinski EVP & General Counsel 03 Novembre 2020 M 17.910 0 0 $0
Craig E Samitt EVP & President, DBG 26 Luglio 2018 M 17.274 0 0 $0
Joseph Swedish Executive Chairman 05 Marzo 2018 S 61.419 0 0 $0
Jacquelyn H Wolf EVP & Chief HR Officer 01 Marzo 2018 A 3.105 0 0 $0
Jose D. Tomas EVP & Chief HR Officer 03 Marzo 2017 F 23.927 0 0 $0
Samuel R Nussbaum MD EVP & Chief Medical Officer 19 Maggio 2015 M 110.973 0 0 $0
Martin B Silverstein EVP & Chief Strategy Officer 01 Maggio 2015 F 23.249 0 0 $0
Kenneth R Goulet EVP, Commercial & Specialty 02 Marzo 2015 A 84.281 0 0 $0
Richard C Zoretic EVP, Gov Business Division 03 Marzo 2014 A 53.572 0 0 $0
John Cannon EVP, GC & Chief PAO 13 Dicembre 2013 S 99.331 0 0 $0
Randal L Brown EVP & Chief HR Officer 04 Settembre 2013 M 30.332 0 0 $0
Lori A Beer EVP, Specialty Businesses & IT 30 Maggio 2013 M 113.955 0 0 $0
Harlan A Levine EVP, CHS 31 Agosto 2012 S 25.244 0 0 $0
Venkata R Madabhushi EVP Sr Bus & Chf Transfrmn Off 02 Aprile 2012 A 45.237 0 0 $0
Miller Martin SVP & Chief Accounting Officer 01 Marzo 2011 A 29.329 0 0 $0
Fluegel M Bradley EVP, Chief Strategy Officer 05 Novembre 2010 M 52.634 0 0 $0
Cynthia S Miller EVP & Chief Actuary 01 Marzo 2010 A 60.757 0 0 $0
Randall J Lewis EVP & Chief Compliance Officer 07 Agosto 2009 M 13.658 0 0 $0
Jamie S Miller SVP & Chief Accounting Officer 03 Marzo 2008 A 25.710 0 0 $0
Alice F Rosenblatt EVP and Chief Actuary 22 Gennaio 2008 S 39.265 0 0 $0
John S Watts JR EVP 07 Dicembre 2007 S 108.311 0 0 $0
Marjorie W Dorr EVP 22 Maggio 2007 M 38.951 0 0 $0
Michael A Stocker EVP 23 Ottobre 2006 M 42.186 0 0 $0
Keith R Faller EVP 12 Settembre 2006 M 83.290 0 0 $0
David S Helwig EVP 18 Agosto 2006 M 55.055 0 0 $0
Thomas G Snead JR EVP 31 Gennaio 2006 M 0 0 0 $0
Ronald J Ponder EVP 18 Novembre 2005 M 55.313 0 0 $0
David R Frick EVP 12 Maggio 2005 S 58.241 0 0 $0
Michael L Smith EVP 18 Febbraio 2005 S 98.810 0 0 $0
Jane E Niederberger Senior Vice President and Chie 17 Maggio 2004 A 28.648 0 0 $0
Ramiro G Peru Direttore 17 Luglio 2026 P 10.908 1 0 $366.050
Robert L Dixon JR Direttore 11 Giugno 2026 S 10.734 0 1 $-60.667
Bahija Jallal Direttore 13 Maggio 2026 A 5.351 0 0 $0
Antonio F Neri Direttore 13 Maggio 2026 A 5.488 0 0 $0
Susan D. Devore Direttore 13 Maggio 2026 A 4.065 0 0 $0
Amy Schulman Direttore 13 Maggio 2026 A 781 0 1 $-7.475
Ryan M. Schneider Direttore 13 Maggio 2026 A 7.163 0 0 $0
Deanna D Strable-Soethout Direttore 13 Maggio 2026 A 2.209 0 0 $0
Steven H Collis Direttore 13 Maggio 2026 A 4.202 1 0 $869.520
Lewis Hay III Direttore 13 Maggio 2026 A 12.070 0 0 $0
Kerry R Clark Direttore 14 Maggio 2025 A 9.640 0 0 $0
Elizebeth E Tallett Direttore 15 Maggio 2024 A 10.291 0 0 $0
Julie A Hill Direttore 20 Maggio 2021 S 31.213 0 0 $0
George A Schaefer JR Direttore 16 Maggio 2018 A 38.864 0 0 $0
William J Ryan Direttore 28 Luglio 2016 S 27.149 0 0 $0
John H Short Direttore 14 Maggio 2014 A 2.981 0 0 $0
Warren Y Jobe Direttore 13 Marzo 2014 G 26.525 0 0 $0
Lenox D Baker JR MD Direttore 08 Marzo 2013 M 71.155 0 0 $0
Susan B Bayh Direttore 21 Maggio 2012 S 0 0 0 $0
Sheila P Burke Direttore 16 Maggio 2012 A 16.200 0 0 $0
Jackie M Ward Direttore 16 Maggio 2012 A 23.806 0 0 $0
William H T Bush Direttore 17 Maggio 2011 M 28.383 0 0 $0
William G Mays Direttore 17 Maggio 2011 A 19.878 0 0 $0
Donald W Riegle JR Direttore 16 Maggio 2011 M 3.894 0 0 $0
Jane G Pisano Direttore 10 Maggio 2010 M 3.692 0 0 $0
Victor S Liss Direttore 10 Maggio 2010 M 4.658 0 0 $0
Larry C Glasscock Direttore 25 Febbraio 2010 M 3.352 0 0 $0
John Zuccotti Direttore 20 Maggio 2009 A · 0 0 $0
Ben L Lytle Direttore 10 Maggio 2005 A 2.128 0 0 $0
Leonard D Schaeffer Direttore 10 Maggio 2005 A 1.041.024 0 0 $0
Allan B Hubbard Direttore 14 Febbraio 2005 M 0 0 0 $0
John Sherman JR Direttore 01 Dicembre 2004 M 4.164 0 0 $0
James W Mcdowell JR Direttore 01 Ottobre 2004 A 1.271 0 0 $0
Dennis J Sullivan JR Direttore 26 Luglio 2004 M 2.837 0 0 $0
Leeba Lessin · 01 Marzo 2013 A 15.451 0 0 $0
Rebecca A Kapustay · 01 Aprile 2005 M 34.557 0 0 $0
SANDERS ELIZABETH A · 03 Marzo 2005 S 35.604 0 0 $0
William B Hart · 01 Ottobre 2004 A 439 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 165 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
IHF · iShares Trust 7,53% 237.106 SH 11 Settembre 2026 Giornaliero
CVGD · Elevation Series Trust 3,56% 13.113 NS 31 Luglio 2026 N-PORT
FDIV · EA Series Trust 1,95% 3.050 NS 31 Luglio 2026 N-PORT
BKDV · BNY Mellon ETF Trust II 1,65% 80.785 NS 31 Luglio 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 1,64% 45.819 NS 31 Luglio 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,59% 36.229 SH 02 Ottobre 2026 Giornaliero
RPV · Invesco Exchange-Traded Fund Trust 1,55% 67.848 SH 02 Ottobre 2026 Giornaliero
PWV · Invesco Exchange-Traded Fund Trust 1,46% 69.517 SH 02 Ottobre 2026 Giornaliero
IYH · iShares Trust 1,46% 127.077 SH 11 Settembre 2026 Giornaliero
SRHQ · Elevation Series Trust 1,41% 7.981 NS 31 Luglio 2026 N-PORT
IMCV · iShares Trust 1,22% 34.046 SH 11 Settembre 2026 Giornaliero
VHT · VANGUARD WORLD FUND 1,22% 645.908 SH 19 Agosto 2026 Giornaliero
FHLC · FIDELITY COVINGTON TRUST 1,19% 104.494 NS 31 Luglio 2026 N-PORT
VMAX · Lattice Strategies Trust 1,18% 1.543 NS 31 Luglio 2026 N-PORT
IXJ · iShares Trust 1,15% 114.143 SH 11 Settembre 2026 Giornaliero
REVS · Columbia ETF Trust I 1,12% 9.954 NS 31 Luglio 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 0,99% 252.365 SH 02 Ottobre 2026 Giornaliero
CURE · Direxion Shares ETF Trust 0,94% 4.273 NS 31 Luglio 2026 N-PORT
NUDV · Nushares ETF Trust 0,92% 1.235 NS 31 Luglio 2026 N-PORT
SYLD · Cambria ETF Trust 0,92% 24.249 NS 31 Luglio 2026 N-PORT
ESMV · iShares Trust 0,91% 170 SH 11 Settembre 2026 Giornaliero
EQIN · Columbia ETF Trust I 0,86% 6.959 NS 31 Luglio 2026 N-PORT
ROUS · Lattice Strategies Trust 0,74% 13.856 NS 31 Luglio 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,73% 15.896 SH 19 Agosto 2026 Giornaliero
RECS · Columbia ETF Trust I 0,73% 112.966 NS 31 Luglio 2026 N-PORT
VLUE · iShares Trust 0,71% 163.004 SH 11 Settembre 2026 Giornaliero
NULC · Nushares ETF Trust 0,69% 1.301 NS 31 Luglio 2026 N-PORT
FBCV · FIDELITY COVINGTON TRUST 0,68% 3.202 NS 31 Luglio 2026 N-PORT
FEUS · FlexShares Trust 0,61% 1.815 NS 31 Luglio 2026 N-PORT
IMCB · iShares Trust 0,61% 24.486 SH 11 Settembre 2026 Giornaliero
FDLO · FIDELITY COVINGTON TRUST 0,60% 22.637 NS 31 Luglio 2026 N-PORT
DIVB · iShares Trust 0,54% 26.159 SH 11 Settembre 2026 Giornaliero
IDRV · iShares Trust 0,53% 143.110 SH 11 Settembre 2026 Giornaliero
RDVI · First Trust Exchange-Traded Fund IV 0,52% 50.065 NS 31 Luglio 2026 N-PORT
XOEF · iShares Trust 0,51% 273 SH 11 Settembre 2026 Giornaliero
IUS · Invesco Exchange-Traded Self-Indexe… 0,50% 12.654 SH 02 Ottobre 2026 Giornaliero
FTA · First Trust Exchange-Traded AlphaDE… 0,49% 18.161 NS 31 Luglio 2026 N-PORT
BSCU · Invesco Exchange-Traded Self-Indexe… 0,47% 13.779.000 02 Ottobre 2026 Giornaliero
BSCS · Invesco Exchange-Traded Self-Indexe… 0,45% 16.207.990 02 Ottobre 2026 Giornaliero
SUSA · iShares Trust 0,45% 43.466 SH 11 Settembre 2026 Giornaliero
ACWV · iShares, Inc. 0,44% 35.074 SH 11 Settembre 2026 Giornaliero
QUVU · Hartford Funds Exchange-Traded Trust 0,42% 2.019 NS 31 Luglio 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,42% 106.873 SH 02 Ottobre 2026 Giornaliero
PALC · Pacer Funds Trust 0,42% 2.320 NS 31 Luglio 2026 N-PORT
EVUS · iShares Trust 0,40% 3.683 SH 11 Settembre 2026 Giornaliero
MGV · VANGUARD WORLD FUND 0,39% 133.635 SH 19 Agosto 2026 Giornaliero
DFUV · Dimensional ETF Trust 0,38% 154.644 NS 31 Luglio 2026 N-PORT
PFIG · Invesco Exchange-Traded Fund Trust … 0,38% 515.000 02 Ottobre 2026 Giornaliero
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0,37% 8.210 NS 31 Luglio 2026 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0,37% 16.818.000 02 Ottobre 2026 Giornaliero
USXF · iShares Trust 0,36% 12.883 SH 11 Settembre 2026 Giornaliero
DFLV · Dimensional ETF Trust 0,36% 65.144 NS 31 Luglio 2026 N-PORT
VIG · VANGUARD SPECIALIZED FUNDS 0,36% 1.200.113 SH 19 Agosto 2026 Giornaliero
FHEQ · Fidelity Greenwood Street Trust 0,35% 8.603 NS 31 Luglio 2026 N-PORT
VYM · VANGUARD WHITEHALL FUNDS 0,34% 847.792 SH 19 Agosto 2026 Giornaliero
CVY · Invesco Exchange-Traded Fund Trust 0,34% 1.030 SH 02 Ottobre 2026 Giornaliero
IWX · iShares Trust 0,34% 31.304 SH 11 Settembre 2026 Giornaliero
USMV · iShares Trust 0,32% 181.462 SH 11 Settembre 2026 Giornaliero
BSCT · Invesco Exchange-Traded Self-Indexe… 0,31% 9.525.000 02 Ottobre 2026 Giornaliero
DGRO · iShares Trust 0,31% 320.084 SH 11 Settembre 2026 Giornaliero
VTV · VANGUARD INDEX FUNDS 0,31% 2.021.174 SH 19 Agosto 2026 Giornaliero
PFM · Invesco Exchange-Traded Fund Trust 0,31% 6.186 SH 02 Ottobre 2026 Giornaliero
IVE · iShares Trust 0,30% 360.968 SH 11 Settembre 2026 Giornaliero
ACIO · ETF Series Solutions 0,29% 18.049 NS 31 Luglio 2026 N-PORT
IUSV · iShares Trust 0,29% 189.556 SH 11 Settembre 2026 Giornaliero
ADME · ETF Series Solutions 0,28% 2.222 NS 31 Luglio 2026 N-PORT
HDUS · Lattice Strategies Trust 0,28% 1.531 NS 31 Luglio 2026 N-PORT
ESG · FlexShares Trust 0,28% 990 NS 31 Luglio 2026 N-PORT
VOOV · VANGUARD ADMIRAL FUNDS 0,28% 48.913 SH 19 Agosto 2026 Giornaliero
SUSL · iShares Trust 0,26% 7.654 SH 11 Settembre 2026 Giornaliero
FEX · First Trust Exchange-Traded AlphaDE… 0,26% 10.930 NS 31 Luglio 2026 N-PORT
DSI · iShares Trust 0,26% 33.146 SH 11 Settembre 2026 Giornaliero
ILCV · iShares Trust 0,25% 8.135 SH 11 Settembre 2026 Giornaliero
FAB · First Trust Exchange-Traded AlphaDE… 0,24% 1.096 NS 31 Luglio 2026 N-PORT
IWD · iShares Trust 0,24% 482.434 SH 11 Settembre 2026 Giornaliero
IQSU · New York Life Investments ETF Trust 0,24% 2.111 NS 31 Luglio 2026 N-PORT
FBUF · Fidelity Greenwood Street Trust 0,24% 152 NS 31 Luglio 2026 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,23% 2.806 NS 31 Luglio 2026 N-PORT
VONV · VANGUARD SCOTTSDALE FUNDS 0,23% 128.096 SH 19 Agosto 2026 Giornaliero
ESGG · FlexShares Trust 0,21% 627 NS 31 Luglio 2026 N-PORT
EUSA · iShares, Inc. 0,21% 9.792 SH 11 Settembre 2026 Giornaliero
FYEE · Fidelity Greenwood Street Trust 0,21% 1.194 NS 31 Luglio 2026 N-PORT
GLBL · Pacer Funds Trust 0,20% 6 NS 31 Luglio 2026 N-PORT
RSP · Invesco Exchange-Traded Fund Trust 0,20% 492.177 SH 02 Ottobre 2026 Giornaliero
ESGU · iShares Trust 0,19% 83.443 SH 11 Settembre 2026 Giornaliero
SIZE · iShares Trust 0,19% 1.938 SH 11 Settembre 2026 Giornaliero
USCL · iShares Trust 0,17% 11.477 SH 11 Settembre 2026 Giornaliero
TOPC · iShares Trust 0,17% 133 SH 11 Settembre 2026 Giornaliero
DFSU · Dimensional ETF Trust 0,16% 9.705 NS 31 Luglio 2026 N-PORT
IWL · iShares Trust 0,16% 8.413 SH 11 Settembre 2026 Giornaliero
XVV · iShares Trust 0,15% 2.493 SH 11 Settembre 2026 Giornaliero
MGC · VANGUARD WORLD FUND 0,15% 42.364 SH 19 Agosto 2026 Giornaliero
QVML · Invesco Exchange-Traded Fund Trust … 0,15% 6.353 SH 02 Ottobre 2026 Giornaliero
OMFL · Invesco Exchange-Traded Self-Indexe… 0,14% 17.682 SH 02 Ottobre 2026 Giornaliero
ESGV · VANGUARD WORLD FUND 0,14% 47.980 SH 19 Agosto 2026 Giornaliero
IVV · iShares Trust 0,14% 2.737.349 SH 11 Settembre 2026 Giornaliero
ACVF · ETF Opportunities Trust 0,14% 548 NS 31 Luglio 2026 N-PORT
ILCB · iShares Trust 0,13% 4.087 SH 11 Settembre 2026 Giornaliero
BKLC · BNY Mellon ETF Trust 0,13% 18.995 NS 31 Luglio 2026 N-PORT
VOO · VANGUARD INDEX FUNDS 0,13% 5.589.584 SH 19 Agosto 2026 Giornaliero
VV · VANGUARD INDEX FUNDS 0,13% 248.024 SH 19 Agosto 2026 Giornaliero
IWB · iShares Trust 0,13% 150.486 SH 11 Settembre 2026 Giornaliero
IYY · iShares Trust 0,13% 9.294 SH 11 Settembre 2026 Giornaliero
PBP · Invesco Exchange-Traded Fund Trust 0,13% 1.291 SH 02 Ottobre 2026 Giornaliero
PTLC · Pacer Funds Trust 0,13% 11.007 NS 31 Luglio 2026 N-PORT
PBUS · Invesco Exchange-Traded Fund Trust … 0,13% 37.605 SH 02 Ottobre 2026 Giornaliero
IWV · iShares Trust 0,12% 59.652 SH 11 Settembre 2026 Giornaliero
ITOT · iShares Trust 0,12% 282.740 SH 11 Settembre 2026 Giornaliero
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0,12% 28.858 NS 31 Luglio 2026 N-PORT
VOTE · TCW ETF Trust 0,12% 3.538 NS 31 Luglio 2026 N-PORT
VONE · VANGUARD SCOTTSDALE FUNDS 0,12% 35.020 SH 19 Agosto 2026 Giornaliero
TOV · EA Series Trust 0,12% 873 NS 31 Luglio 2026 N-PORT
DFUS · Dimensional ETF Trust 0,12% 65.434 NS 31 Luglio 2026 N-PORT
DXUV · Dimensional ETF Trust 0,12% 1.719 NS 31 Luglio 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0,12% 820 NS 31 Luglio 2026 N-PORT
VOXP · Advisors Series Trust 0,12% 18 NS 31 Luglio 2026 N-PORT
QDPL · Pacer Funds Trust 0,12% 5.228 NS 31 Luglio 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,11% 6.834.097 SH 19 Agosto 2026 Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS 0,11% 17.880 SH 19 Agosto 2026 Giornaliero
TOK · iShares Trust 0,11% 620 SH 11 Settembre 2026 Giornaliero
DFAC · Dimensional ETF Trust 0,11% 134.751 NS 31 Luglio 2026 N-PORT
PHDG · Invesco Actively Managed Exchange-T… 0,11% 171 SH 02 Ottobre 2026 Giornaliero
TILT · FlexShares Trust 0,10% 6.004 NS 31 Luglio 2026 N-PORT
HCMT · Direxion Shares ETF Trust 0,10% 1.508 NS 31 Luglio 2026 N-PORT
URTH · iShares, Inc. 0,10% 19.735 SH 11 Settembre 2026 Giornaliero
DCOR · Dimensional ETF Trust 0,10% 8.835 NS 31 Luglio 2026 N-PORT
DFAU · Dimensional ETF Trust 0,10% 31.680 NS 31 Luglio 2026 N-PORT
SPXL · Direxion Shares ETF Trust 0,09% 16.978 NS 31 Luglio 2026 N-PORT
GLOF · iShares Trust 0,09% 455 SH 11 Settembre 2026 Giornaliero
LGDX · Tidal Trust III 0,09% 342 NS 31 Luglio 2026 N-PORT
ACWI · iShares Trust 0,09% 69.481 SH 11 Settembre 2026 Giornaliero
EQAL · Invesco Exchange-Traded Fund Trust … 0,09% 1.815 SH 02 Ottobre 2026 Giornaliero
CRBN · iShares Trust 0,08% 2.188 SH 11 Settembre 2026 Giornaliero
NEAR · iShares U.S. ETF Trust 0,08% 3.886.000 SH 11 Settembre 2026 Giornaliero
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,07% 290.778 SH 19 Agosto 2026 Giornaliero
PICK · iShares, Inc. 0,06% 266.862 SH 11 Settembre 2026 Giornaliero
DFVX · Dimensional ETF Trust 0,05% 720 NS 31 Luglio 2026 N-PORT
LRGF · iShares Trust 0,03% 2.746 SH 11 Settembre 2026 Giornaliero
VSS · VANGUARD INTERNATIONAL EQUITY INDEX… 0,03% 571.538 SH 19 Agosto 2026 Giornaliero
SCZ · iShares Trust 0,03% 625.241 SH 11 Settembre 2026 Giornaliero
PEVC · Pacer Funds Trust 0,02% 1 NS 31 Luglio 2026 N-PORT
DYNF · BlackRock ETF Trust 0,01% 13.133 SH 11 Settembre 2026 Giornaliero
IPAC · iShares Trust 0,01% 52.224 SH 11 Settembre 2026 Giornaliero
VPL · VANGUARD INTERNATIONAL EQUITY INDEX… 0,01% 158.652 SH 19 Agosto 2026 Giornaliero
WSML · iShares Trust 0,01% 9.378 SH 11 Settembre 2026 Giornaliero
IEFA · iShares Trust 0,00% 1.291.652 SH 11 Settembre 2026 Giornaliero
IDEV · iShares Trust 0,00% 211.325 SH 11 Settembre 2026 Giornaliero
IXUS · iShares Trust 0,00% 168.378 SH 11 Settembre 2026 Giornaliero
VXUS · VANGUARD STAR FUNDS 0,00% 2.181.735 SH 19 Agosto 2026 Giornaliero
VEA · VANGUARD TAX-MANAGED FUNDS 0,00% 1.468.301 SH 19 Agosto 2026 Giornaliero
VSGX · VANGUARD WORLD FUND 0,00% 30.111 SH 19 Agosto 2026 Giornaliero
BIV · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
BLV · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
BSV · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
BND · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
VUSB · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
VCRB · VANGUARD MALVERN FUNDS · · 15 Luglio 2026 Giornaliero
VPLS · VANGUARD MALVERN FUNDS · · 15 Luglio 2026 Giornaliero
VSDB · VANGUARD MALVERN FUNDS · · 15 Luglio 2026 Giornaliero
VCSH · VANGUARD SCOTTSDALE FUNDS · · 15 Luglio 2026 Giornaliero
VCIT · VANGUARD SCOTTSDALE FUNDS · · 15 Luglio 2026 Giornaliero
VCLT · VANGUARD SCOTTSDALE FUNDS · · 15 Luglio 2026 Giornaliero
VTC · VANGUARD SCOTTSDALE FUNDS · · 30 Luglio 2026 Giornaliero
BNDW · VANGUARD SCOTTSDALE FUNDS · · 30 Luglio 2026 Giornaliero
VCEB · VANGUARD WORLD FUND · · 30 Luglio 2026 Giornaliero

ELV Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21
rating · 29 analisti COMPRA
Target mediano $460.00 +16,2%
7 24,1% Acquisto forte
12 41,4% Compra
10 34,5% Mantieni
0 0,0% Vendi
0 0,0% Vendita forte

Target Price a 12 Mesi

21 analisti · 2026-10-01

Target medio $451.38 +14,1%

Ora Prezzo attuale $395.70
Basso$393.00 Media$451.38 Alto$492.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
ELV $77.37B 13.9 12.5% 2.8% 13.3% ·
UNH $299.08B 25.0 11.8% 2.7% 12.0% ·
HUM $50.90B 26.0 10.1% 0.92% 7.0% ·
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9% ·
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
CLOV · -5.1 40.3% -4.5% -26.2% ·
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%
ALHC $4.03B · 46.1% -0.02% -0.52% ·

Ultime notizie Notizie recenti che menzionano questa società

23

Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento

25

Nessun segnale aperto al momento — nessuna scheda è compilata, e questo è onesto.

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Fonte: SEC 10-Q depositato Lug 15, 2026